Altogether, our findings from CSF and previous plasma studies suggest that the concentration of GLAST+ EVs in MS samples, and specifically in PPMS, may show a consistent decline in both the CNS and periphery, supporting the hypothesis of their CNS origin. This evidence concerns the gene SLC1A3 and myeloid sarcoma.